Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease (Q36304089)

13 August 2017

1 reference

title

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

13 August 2017

main subject

0 references

author name string

Jon O Lundberg

1

1 reference

13 August 2017

Per M Hellström

2

1 reference

13 August 2017

Magne K Fagerhol

3

1 reference

13 August 2017

Eddie Weitzberg

4

1 reference

13 August 2017

Arne G Roseth

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Nature Reviews Gastroenterology & Hepatology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

96-102

1 reference

Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Functional and clinical aspects of the myelomonocyte protein calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Nitric oxide and inflammation: the answer is blowing in the wind

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Exhaled NO and plasma cGMP increase after endotoxin infusion in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Management of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Microscopic colitis: a missed diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

Cost-effectiveness of endoscopy in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Greatly increased luminal nitric oxide in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Colonic production of nitric oxide gas in ulcerative colitis, collagenous colitis and uninflamed bowel

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Increased rectal nitric oxide in children with active inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Increased nitric oxide in infective gastroenteritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Increased nitric oxide production in collagenous and lymphocytic colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Calprotectin, a faecal marker of organic gastrointestinal abnormality

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Fecal calprotectin levels in healthy children studied with an improved assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0094

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0094

1 reference

Dimensions Publication ID

13 August 2017

1040369892

0 references

1 reference